Loading...
XASX
PME
Market cap12bUSD
Jun 18, Last price  
167.61AUD
1D
-0.76%
1Q
39.61%
Jan 2017
3,391.88%
IPO
12,134.31%
Name

Pro Medicus Ltd

Chart & Performance

D1W1MN
XASX:PME chart
P/E
151.98
P/S
82.24
EPS
1.10
Div Yield, %
0.33%
Shrs. gr., 5y
0.04%
Rev. gr., 5y
30.24%
Revenues
213m
+31.89%
11,298,00012,539,0009,157,0009,940,00019,197,00013,969,00011,313,00011,154,00014,268,00017,490,00027,521,00031,597,00033,872,00050,105,00056,821,00067,884,00093,461,000124,900,000161,429,000212,905,000
Net income
115m
+39.16%
6,115,0007,052,0007,933,0005,683,0003,920,000503,0001,791,0005,131,0001,509,0003,217,0006,368,0009,321,0009,965,00019,125,00023,076,00030,850,00044,442,00060,648,00082,794,000115,217,000
CFO
111m
+28.30%
6,910,0005,805,0008,810,0005,477,0006,839,0006,250,0005,876,0003,813,0004,233,0004,183,00011,254,00014,829,00013,873,00024,658,00031,592,00039,020,00062,225,00064,772,99986,776,000111,332,000
Dividend
Sep 03, 20250.3 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Based in Richmond, Australia, and established in 1983, Pro Medicus Limited is a leading developer and provider of cutting-edge healthcare imaging software and support services. The company caters to a diverse range of medical institutions, including hospitals and diagnostic imaging facilities, across Australia, North America, and Europe. Its comprehensive product suite features a proprietary Radiology Information System (RIS), designed for efficient practice management, which comes complete with training, installation, professional services, and ongoing post-sales support (marketed under names like Visage RIS). Additionally, Pro Medicus offers Promedicus.net, an e-health platform, and advanced healthcare imaging software that empowers radiologists and clinicians with robust visualization capabilities for 2D, 3D, and 4D medical images, alongside its Picture Archiving and Communication System (PACS)/digital imaging solutions (e.g., Visage 7). The company also provides integration products and the Visage Ease Pro mobile application, allowing users to remotely interpret diagnostic imaging studies stored on a Visage 7 server.
IPO date
Oct 10, 2000
Employees
79
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT